Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.
about
Modified fluorescence in situ hybridization methods using pathology archives.Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours.Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients.Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.1p/19q testing has no significance in the workup of glioblastomas.Molecular classification of low-grade diffuse gliomas.Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsPTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951The future of high-grade glioma: Where we are and where are we going.Molecular profile of oligodendrogliomas in young patientsCDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.Automated Analysis of 1p/19q Status by FISH in Oligodendroglial Tumors: Rationale and Proposal of an Algorithm.How molecular testing can help (and hurt) in the workup of gliomas.Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.Retrospective review of prognostic factors, including 1p19q deletion, in low-grade oligodendrogliomas and a review of recent published works.Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.Anaplastic glioma: current treatment and management.Molecular diagnostics: techniques and recommendations for 1p/19q assessment.The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.Moving toward molecular classification of diffuse gliomas in adults.Correlation of in vitro infiltration with glioma histological type in organotypic brain slices.Something old and something new about molecular diagnostics in gliomas.Glioblastomas: correlation between oligodendroglial components, genetic abnormalities, and prognosis.Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.1p/19q-driven prognostic molecular classification for high-grade oligodendroglial tumors.Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.Reclassification of oligoastrocytomas by loss of heterozygosity studies.Anaplastic oligodendroglioma with ganglioglioma-like maturation.Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.Molecular pathology and clinical characteristics of oligodendroglial neoplasms.
P2860
Q33224214-B6E37A15-A3C9-4F34-81F8-34FB9930468DQ33232891-6B8A594D-9EA5-4449-A9DF-789D6BC3B16CQ33535985-CB8E7208-DD74-4A62-9B59-0002A40F1150Q33711322-55C5035D-B187-476B-9A0D-49386C739FE6Q33893445-DCFD2308-BEBA-4A93-814B-AB95FC9EA06CQ34358250-9229666F-73D5-4DC8-BF63-A2EEFB0F35D9Q34388126-D56680D7-5550-4BDD-8A45-B5C57BEC6A46Q34480582-7F01BCD2-825E-41FB-9751-938E3A6566CDQ34484407-E2EAD2C2-5811-40FD-89FD-875B07F90A13Q34769937-E868158E-3C55-4866-9153-BF6056319D2EQ34990522-867FA93A-EE0A-4AA1-AB89-176EAFAA3B52Q35114090-442003A2-4879-43CB-AADA-202FBC5E2677Q35225293-1AC2C0B7-384C-43CB-8805-4F62081AE23FQ35418206-0AC4D5E1-A737-4BF9-AA88-DDFD06D85BF5Q35419379-914BCD4A-522E-45C0-814A-0F841217AA7CQ35634042-BC3817FA-950C-4279-9C3B-C92A3E09E0B8Q35681251-0A772880-97F3-4979-ADAE-99966A884C79Q35770275-523BE8CB-FC83-44C3-A2CA-A2A36E99CE20Q35848375-03C7E32E-9354-4827-B2AF-31645B8505D2Q36866053-FE0324C9-FC34-46BD-9A87-2EBFB2E5CC10Q36919406-E10E436A-C295-4F1E-9A5E-FB6A5ABC31EDQ37558556-9B578C45-CE84-4272-BCB8-7D5190BC8753Q37815544-18AE6780-20B0-4C13-AFD6-E26415B99E5FQ38456018-DC48E23A-A393-4557-9A97-0190C2ACBEF3Q38627124-40396266-3E15-4B20-9B0C-88ACCF1AE930Q38844224-573D0317-842B-4EE6-B0BB-83DAD649D04EQ41201032-C8A5EB97-A5EA-47BF-987D-F96889E180FBQ41890894-13B6F807-9955-42FB-BABF-29A8E274BAA3Q42157104-B7B0393B-9688-4631-ADA7-201B71201592Q43238974-416E6275-4D75-4D5A-8F31-82B350B79693Q44230849-DB893878-19FD-4801-9C3D-1762911E3544Q44661979-08118E45-DC21-4ADB-900E-9D9D8AB89775Q48446221-CFEAA8EE-011B-4B6C-8A2F-C47BB9A62C69Q48588128-1EAE52A4-FF77-4E35-AFD4-8166D50A0F53Q48626706-A046A5AD-C8A1-4015-A8DC-8017EE44D218Q48676116-DFD43D9B-A617-46AF-A443-4C71B12D9925Q48720543-9C038C66-E7DC-4EEF-A1E6-850A962BFDD5Q48743716-3CD1D02E-1A55-40CE-A107-2BB058FBCFF2Q48831747-1227D3AA-D670-415F-9400-E7ED8D860F12Q48874973-21BA4F69-0038-4CEB-994E-8537AF7EE9DC
P2860
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Clinical utility of fluorescen ...... ndroglial/astrocytic features.
@en
Clinical utility of fluorescence in situ hybridization
@nl
type
label
Clinical utility of fluorescen ...... ndroglial/astrocytic features.
@en
Clinical utility of fluorescence in situ hybridization
@nl
prefLabel
Clinical utility of fluorescen ...... ndroglial/astrocytic features.
@en
Clinical utility of fluorescence in situ hybridization
@nl
P2093
P2860
P356
P1476
Clinical utility of fluorescen ...... ndroglial/astrocytic features.
@en
P2093
Bernd W Scheithauer
Christine E Fuller
Kathryn Trinkaus
Kevin A Roth
Peter C Burger
Richard Lytle
Robert E Schmidt
Ruma Banerjee
P2860
P304
P356
10.1093/JNEN/62.11.1118
P50
P577
2003-11-01T00:00:00Z